Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wiek H van Gilst

Showing results (1-10 of 244) with videos related to

Pageof 25
Sort By:
Current Opinion in Cardiology|June 9, 2007
Angiotensin converting enzyme inhibition in cardiovascular risk populations: a practical approach to identify the patient who will benefit mostFolkert W Asselbergs, Wiek H van Gilst
Kidney International. Supplement|October 16, 2004
Framingham score and microalbuminuria: combined future targets for primary prevention?Folkert W Asselbergs, Hans L Hillege, Wiek H van Gilst
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 26, 2008
Vascular dysfunction in adriamycin nephrosis: different effects of adriamycin exposure and nephrosisNadir Ulu, Hendrik Buikema, Wiek H van Gilst, et al.
Journal of Cardiovascular Pharmacology|November 25, 2005
Improvement of EDHF by chronic ACE inhibition declines rapidly after withdrawal in rats with myocardial infarctionBart Westendorp, Regien G Schoemaker, Wiek H van Gilst, et al.
Basic Research in Cardiology|November 28, 2015
Emerging role of liver X receptors in cardiac pathophysiology and heart failureMegan V Cannon, Wiek H van Gilst, Rudolf A de Boer
European Journal of Pharmacology|April 22, 2008
Caveolae and endothelial dysfunction: filling the caves in cardiovascular diseaseYing Xu, Hendrik Buikema, Wiek H van Gilst, et al.
The Canadian Journal of Cardiology|January 9, 2003
Angiotensin receptors in the cardiovascular systemLodewijk J Wagenaar, Adriaan A Voors, Hendrik Buikema, et al.
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|January 18, 2017
Improvement of endothelial dysfunction in experimental heart failure by chronic RAAS-blockade: ACE-inhibition or AT1-receptor blockade?Lodewijk J Wagenaar, Hendrik Buikema, Yigal M Pinto, et al.
European Journal of Pharmacology|April 18, 2008
Angiotensin-(1-7): pharmacological properties and pharmacotherapeutic perspectivesDilek Iusuf, Robert H Henning, Wiek H van Gilst, et al.
Clinical Science (London, England : 1979)|January 14, 2009
The role of the renin-angiotensin-aldosterone system in cardiovascular progenitor cell functionCheng Qian, Regien G Schoemaker, Wiek H van Gilst, et al.
Pageof 25

Showing results (1-10 of 244) with videos related to

Sort By:
Pageof 25
Current Opinion in Cardiology|June 9, 2007
Angiotensin converting enzyme inhibition in cardiovascular risk populations: a practical approach to identify the patient who will benefit mostFolkert W Asselbergs, Wiek H van Gilst
Kidney International. Supplement|October 16, 2004
Framingham score and microalbuminuria: combined future targets for primary prevention?Folkert W Asselbergs, Hans L Hillege, Wiek H van Gilst
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 26, 2008
Vascular dysfunction in adriamycin nephrosis: different effects of adriamycin exposure and nephrosisNadir Ulu, Hendrik Buikema, Wiek H van Gilst, et al.
Journal of Cardiovascular Pharmacology|November 25, 2005
Improvement of EDHF by chronic ACE inhibition declines rapidly after withdrawal in rats with myocardial infarctionBart Westendorp, Regien G Schoemaker, Wiek H van Gilst, et al.
Basic Research in Cardiology|November 28, 2015
Emerging role of liver X receptors in cardiac pathophysiology and heart failureMegan V Cannon, Wiek H van Gilst, Rudolf A de Boer
European Journal of Pharmacology|April 22, 2008
Caveolae and endothelial dysfunction: filling the caves in cardiovascular diseaseYing Xu, Hendrik Buikema, Wiek H van Gilst, et al.
The Canadian Journal of Cardiology|January 9, 2003
Angiotensin receptors in the cardiovascular systemLodewijk J Wagenaar, Adriaan A Voors, Hendrik Buikema, et al.
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|January 18, 2017
Improvement of endothelial dysfunction in experimental heart failure by chronic RAAS-blockade: ACE-inhibition or AT1-receptor blockade?Lodewijk J Wagenaar, Hendrik Buikema, Yigal M Pinto, et al.
European Journal of Pharmacology|April 18, 2008
Angiotensin-(1-7): pharmacological properties and pharmacotherapeutic perspectivesDilek Iusuf, Robert H Henning, Wiek H van Gilst, et al.
Clinical Science (London, England : 1979)|January 14, 2009
The role of the renin-angiotensin-aldosterone system in cardiovascular progenitor cell functionCheng Qian, Regien G Schoemaker, Wiek H van Gilst, et al.
Pageof 25